FDA approves first drug for neurotrophic keratitis, a rare eye disease

SILVER SPRING, Md., Aug. 22, 2018 /PRNewswire/ -- The U.S. Food and Drug Administration today approved the first drug, Oxervate (cenegermin), for the treatment of neurotrophic keratitis, a rare disease affecting the cornea (the clear layer that covers the colored portion of the front of...